Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology.
Eekers DB, In 't Ven L, Roelofs E, Postma A, Alapetite C, Burnet NG, Calugaru V, Compter I, Coremans IEM, Høyer M, Lambrecht M, Nyström PW, Méndez Romero A, Paulsen F, Perpar A, de Ruysscher D, Renard L, Timmermann B, Vitek P, Weber DC, van der Weide HL, Whitfield GA, Wiggenraad R, Troost EGC; “European Particle Therapy Network” of ESTRO. Eekers DB, et al. Among authors: calugaru v. Radiother Oncol. 2018 Jul;128(1):37-43. doi: 10.1016/j.radonc.2017.12.013. Epub 2018 Mar 13. Radiother Oncol. 2018. PMID: 29548560 Free article. Review.
The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
Passeri T, Gutman T, Hamza A, Adle-Biassette H, Girard E, Beaurepere R, Tariq Z, Mariani O, Dahmani A, Bourneix C, Abbritti R, Driouch K, Bohec M, Servant N, Baulande S, Decaudin D, Guichard JP, Calugaru V, Feuvret L, Guinebretière JM, Champion L, Bièche I, Froelich S, Mammar H, Masliah-Planchon J. Passeri T, et al. Among authors: calugaru v. J Neurosurg. 2023 Apr 7;139(5):1270-1280. doi: 10.3171/2023.1.JNS222180. Print 2023 Nov 1. J Neurosurg. 2023. PMID: 37029667
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
Tao Y, Sun XS, Pointreau Y, Le Tourneau C, Sire C, Kaminsky MC, Coutte A, Alfonsi M, Calderon B, Boisselier P, Martin L, Miroir J, Ramee JF, Delord JP, Clatot F, Rolland F, Villa J, Magne N, Elicin O, Gherga E, Nguyen F, Lafond C, Bera G, Calugaru V, Geoffrois L, Chauffert B, Damstrup L, Crompton P, Ennaji A, Gollmer K, Nauwelaerts H, Bourhis J. Tao Y, et al. Among authors: calugaru v. Eur J Cancer. 2023 Apr;183:24-37. doi: 10.1016/j.ejca.2022.12.015. Epub 2023 Jan 9. Eur J Cancer. 2023. PMID: 36796234 Free article. Clinical Trial.
[Proposal for the delineation of postoperative primary clinical target volumes in maxillary sinus and nasal cavity cancers].
Guillemin F, Blanchard P, Boisselier P, Brahimi Y, Calugaru V, Coutte A, Gillon P, Graff P, Liem X, Modesto A, Pointreau Y, Racadot S, Sun XS, Bellini R, Pham Dang N, Saroul N, Bourhis J, Thariat J, Biau J, Lapeyre M. Guillemin F, et al. Among authors: calugaru v. Cancer Radiother. 2024 Apr;28(2):218-227. doi: 10.1016/j.canrad.2023.12.001. Epub 2024 Apr 9. Cancer Radiother. 2024. PMID: 38599940 French.
Clinical complementarities between proton and carbon therapies.
Mazeron JJ, Noel G, Feuvret L, Calugaru V, Racadot S. Mazeron JJ, et al. Among authors: calugaru v. Radiother Oncol. 2004 Dec;73 Suppl 2:S50-2. doi: 10.1016/s0167-8140(04)80013-6. Radiother Oncol. 2004. PMID: 15971309
[Is proton beam therapy the future of radiotherapy? Part I: clinical aspects].
Bouyon-Monteau A, Habrand JL, Datchary J, Alapetite C, Bolle S, Dendale R, Feuvret L, Helfre S, Calugaru V, Cosset JM, Bey P. Bouyon-Monteau A, et al. Among authors: calugaru v. Cancer Radiother. 2010 Dec;14(8):727-38. doi: 10.1016/j.canrad.2010.01.008. Epub 2010 Apr 27. Cancer Radiother. 2010. PMID: 20427218 Review. French.
[Update of clinical programs using hadrontherapy 2008-2012].
Habrand JL, Datchary J, Alapetite C, Bolle S, Calugaru V, Feuvret L, Helfre S, Stefan D, Delacroix S, Demarzi L, Dendale R. Habrand JL, et al. Among authors: calugaru v. Cancer Radiother. 2013 Oct;17(5-6):400-6. doi: 10.1016/j.canrad.2013.07.141. Epub 2013 Sep 2. Cancer Radiother. 2013. PMID: 24007956 Review. French.
Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus.
Lambrecht M, Eekers DBP, Alapetite C, Burnet NG, Calugaru V, Coremans IEM, Fossati P, Høyer M, Langendijk JA, Méndez Romero A, Paulsen F, Perpar A, Renard L, de Ruysscher D, Timmermann B, Vitek P, Weber DC, van der Weide HL, Whitfield GA, Wiggenraad R, Roelofs E, Nyström PW, Troost EGC; work package 1 of the taskforce “European Particle Therapy Network” of ESTRO. Lambrecht M, et al. Among authors: calugaru v. Radiother Oncol. 2018 Jul;128(1):26-36. doi: 10.1016/j.radonc.2018.05.001. Epub 2018 May 17. Radiother Oncol. 2018. PMID: 29779919 Review.
Long term outcome of skull-base chondrosarcoma patients treated with high-dose proton therapy with or without conventional radiation therapy.
Weber DC, Murray F, Combescure C, Calugaru V, Alapetite C, Albertini F, Bolle S, Goudjil F, Pica A, Walser M, Mammar H, Bachtiary B, Lomax T, Noël G, Dendale R, Feuvret L. Weber DC, et al. Among authors: calugaru v. Radiother Oncol. 2018 Dec;129(3):520-526. doi: 10.1016/j.radonc.2018.06.040. Epub 2018 Jul 17. Radiother Oncol. 2018. PMID: 30021697
106 results